Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

  title={Asenapine: a novel psychopharmacologic agent with a unique human receptor signature},
  author={M. Shahid and G. Walker and S. Zorn and E. Wong},
  journal={Journal of Psychopharmacology},
  pages={65 - 73}
  • M. Shahid, G. Walker, +1 author E. Wong
  • Published 2009
  • Medicine, Psychology
  • Journal of Psychopharmacology
  • Asenapine is a novel psychopharmacologic agent under development for the treatment of schizophrenia and bipolar disorder. We determined and compared the human receptor binding affinities and functional characteristics of asenapine and several antipsychotic drugs. Compounds were tested under comparable assay conditions using cloned human receptors. In comparison with the antipsychotics, asenapine showed high affinity and a different rank order of binding affinities (pK i) for serotonin receptors… CONTINUE READING
    Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia
    • 57
    Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism
    • 35
    Asenapine effects in animal models of psychosis and cognitive function
    • 45
    • PDF


    Publications referenced by this paper.
    Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.
    • 603
    • Highly Influential
    5-ht6 receptors.
    • 262
    Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence
    • 662
    • PDF
    A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
    • 729
    • PDF